ThursdayJun 10, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Reports on the Medical Benefits of the “Munchies”

Reported on the therapeutic benefit of munchies for nausea and vomiting Recorded over 14,500 sessions from patients seeking relief from nausea Munchies are a medical benefit for those going through chemotherapy or diagnosed with cachexia, also known as a wasting disorder RYAH Group (CSE: RYAH), the leading data technology company in plant-based medicine, collects data through its IoT dose-measuring devices and AI analytics. Recently the company reported on The Therapeutic Benefit of the Munchies for Nausea and Vomiting. The full article can be found at https://ibn.fm/mgkad. RYAH is uniquely positioned to collect essential data that can lead to more personalized…

Continue Reading

WednesdayJun 09, 2021 12:48 pm

Digitization May Be the Future of the Healthcare Sector

A report that was recently released highlights that medical service leaders from various countries believe that being prepared for crises that may arise in the future and strengthening resilience should be a top priority. The senior healthcare leaders from countries such as India, Germany and the United States, were questioned about their digitization plans. Their responses were recorded through surveys. The coronavirus pandemic has affected many industries and economies, with more nations adopting telemedicine in their healthcare sectors and using video and phone appointments to provide consultations, as opposed to in-person visits. IDC, an industry analyst firm, forecasts that in…

Continue Reading

WednesdayJun 09, 2021 9:15 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Files International Patent to Protect Potential Patient Coverage in 153 Countries

Cybin submits first-ever Patent Cooperation Treaty (“PCT”) filing By filing a single PCT application, the company simultaneously seeks protection for its proprietary drug treatments in a large number of countries Cybin filed the PCT application to provide broad international patent protection of key intellectual property Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, continues to focus on its goal to improve the lives of those suffering from mental illness by changing the expectation of treatment. As part of that mission, the company has filed an international patent application that would provide the potential to obtain patent…

Continue Reading

TuesdayJun 08, 2021 2:44 pm

Researchers Find Global Variation in Recorded Distribution of Brain Tumors

A recent study published in “Neuro-Oncology” has found that brain tumor global histology distribution differs significantly, which suggests inconsistencies in data quality and registration practices. Researchers examined data from more than 280 cancer registries that took part in the CONCORD-3 study, which was made up of more than 670,000 adults and 67,000 children with brain tumors diagnosed between 2000 and 2014. Some countries were excluded from the analysis as their records didn’t have viable morphology codes. The study population was made up of more than 600,000 adults, aged between 15 to 99 years, and more than 60,000 children, aged between…

Continue Reading

TuesdayJun 08, 2021 9:30 am

Brain Scientific Inc.’s (BRSF) Marketing Director Interviewed for One of Top News Source for Startups

Irina Nazarova, Brain Scientific’s marketing director, interviewed for Grit Daily, one of the top news hubs for startups, discussing exciting new product developments the company is working on BRSF is poised to extend the universe of EEG use cases, expanding possible markets for its disruptive products Irina Nazarova, marketing director of Brain Scientific (OTCQB: BRSF), was interviewed for Grit Daily News, the top news source on Millennial and Gen Z startups, where she presented the latest work that the company does in the space of neurology medical devices (https://ibn.fm/CeYY3). Nazarova, who has significant marketing experience as the former Editor-in-Chief at…

Continue Reading

TuesdayJun 08, 2021 9:15 am

United Medical Equipment Business Solutions Network Inc. Stands Out As Trusted Supplier of Life Saving Personal Protective Equipment

With demand for PPE exploding virtually overnight due to the pandemic, PPE-related fraud involving counterfeit or faulty equipment surged As a reliable source of everything PPE-related, UME has established itself as a go-to provider of premier equipment that can be trusted  The company pivoted its business model when the pandemic started to seize growing market opportunity and provide reliable, high-quality PPE essentials amid the virus outbreak United Medical Equipment Business Solutions Network ("UME") ("UMEBSNI"), the distributor of a comprehensive line of COVID-19 products, stands out as a trusted source of reliable and authentic personal protective equipment (“PPE”) supplies. The SARS-CoV-2 virus is mainly transmitted by inhalation of…

Continue Reading

TuesdayJun 08, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Rising Above Canada’s Medical Cannabis Growing Pains

The number of federally registered Canadians is down, but the number of users is not A large percentage of Canadians are managing their treatment without the help or oversite of a healthcare professional  Retailers and product suppliers also benefit from RYAH’s suite of dose-control products, generating recurring revenue streams and strengthening their product offerings  RYAH Group (CSE: RYAH), a health care analytics and technology company, has developed and uses dose-measuring IoT devices to collect HIPPA-compliant data to improve future medical treatments. The Company is working with doctors, government, and university research centers to reduce the variations in their treatment plans…

Continue Reading

MondayJun 07, 2021 3:00 pm

Study Discovers Chemical Reaction That May Help in Managing Epilepsy

Scientists at Case Western Reserve University have discovered a possible new approach to control epileptic seizures. Lin Mei, chair of the Department of Neurosciences at the university’s School of Medicine and lead of the study, stated that the researchers identified a new chemical reaction that may help to better manage epileptic seizures. The research, which was conducted using mice models, was reported in the “Journal of Clinical Investigation.” Epilepsy is a neurological disorder that brings about periods of unusual behavior and seizures, loss of awareness and sensations when brain activity becomes abnormal. The human brain has more than 85 billion…

Continue Reading

MondayJun 07, 2021 12:19 pm

Brain Scientific Inc. (BRSF) Expands Commercialization of its Pediatric NeuroCap(TM); Announces Maine Medical Center Has Placed Order

BRSF announced that Maine Medical Center, a teaching hospital providing health care across Portland, Maine, and northern New England, has placed an order for Pediatric NeuroCap(TM), Company's pediatric disposable EEG headset. EEG testing is increasingly needed in pediatric patients, where neurological workup faces even bigger challenges than in adults. BRSF has developed disposable EEG caps for adults and children to meet the needs of the pediatric neuro testing market; partners with medical facilities to expand its unique technology and respond to unmet market need. Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare technology company developing solutions in the brain diagnostics space,…

Continue Reading

FridayJun 04, 2021 11:39 am

Contrast-Enhanced MRI’s May Better Traumatic Brain Injury Diagnosis

Growing public attention on the traumatic brain injuries that football players suffer while playing the sport has led to various studies on the topic being conducted. Among them is a study conducted last year and approved by the institutional review board of the Soroka University Medical Center. The study recruited 26 nonathletes, 27 athletes who played a noncontact sport and 42 amateur American football players to participate in the study. All the participants gave their informed consent to be part of the study, with the first two groups being classified under the control group. The investigators’ primary goal was to…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050